Barings’s Bio-Techne TECH Stock Holding History

Barings’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,832	Closed	-$246K	–	306
2022 Q2	$246K	Buy	+2,832	New	+$265K	0.01%	275

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Barings's TECH Position: Q3 2022 in Review

Barings sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 2,832 shares — an estimated $246K sold.

Barings first reported a position in TECH in Q2 2022 and held it in 1 quarter. The position peaked at $246K in Q2 2022. 535 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

Barings reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
Barings sold 2,832 Bio-Techne shares in Q3 2022, an estimated $246K.
Barings first reported a position in Bio-Techne in Q2 2022 and held it in 1 quarter.
Barings's Bio-Techne position peaked at $246K in Q2 2022.
535 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.